The decrease of sRAGE in type 2 diabetes and obesity has been explained by the beneficial role of sRAGE and its function as decoy to capture the circulating AGEs preventing activation of RAGE signaling pathway as it still possesses the V-ligand essential for ligand binding (1). Here, AGER is linked to Obesity.